Bruker (BRKR) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Bruker (BRKR) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | -54.61% |
| 10 | Bruker | 9.16 Bn | 9.16 Bn | 379.80 Mn | -65.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.56% |
| Dec 31, 2025 | 54.01% |
| Sep 30, 2025 | -143.47% |
| Jun 30, 2025 | -75.26% |
| Mar 31, 2025 | -81.27% |
| Dec 31, 2024 | -7.26% |
| Sep 30, 2024 | -81.61% |
| Jun 30, 2024 | -86.14% |
| Mar 31, 2024 | -55.64% |
| Dec 31, 2023 | -84.34% |
| Sep 30, 2023 | 575.90% |
| Jun 30, 2023 | 219.63% |
| Mar 31, 2023 | 24.12% |
| Dec 31, 2022 | 72.49% |
| Sep 30, 2022 | 184.55% |
| Jun 30, 2022 | -147.48% |
| Mar 31, 2022 | -39.24% |
| Dec 31, 2021 | 3.34% |
| Sep 30, 2021 | -94.89% |
| Jun 30, 2021 | 166.92% |